Therapeutic Classification: anti-infectives
Pharmacologic Classification: cyclic lipopeptide antibacterial agents
REMS
Staphylococcus aureus
bacteremia, including right-sided infective endocarditis caused by methicillin-susceptible and methicillin-resistant strains (in adults).Staphylococcus aureus
bacteremia (in pediatric patients).Spectrum:
Absorption: IV administration results in complete bioavailability.
Distribution: Unknown.
Protein Binding: 92%.
Half-Life: 8.1 hr.
Contraindicated in:
Use Cautiously in:
CV: hypertension, hypotension
Derm: DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), pruritus, rash
GI: ↑liver enzymes, CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD), constipation, diarrhea, nausea, vomiting
GU: renal impairment
Hemat: anemia
Local: injection site reactions
MS: ↑creatine kinase
Neuro: dizziness
Resp: dyspnea, EOSINOPHILIC PNEUMONIA
Misc: ANGIOEDEMA, fever
Drug-drug:
Complicated Skin/Skin Structure Infections
Renal Impairment
Staphylococcus aureus Bacteremia/Right-Sided Infective Endocarditis
Renal Impairment
Staphylococcus aureus Bacteremia
Lab Test Considerations:
IV Administration: